Disclosure Of Entity's Operating Segments [Text Block]

Sopharma Trading AD - Filing #6022483

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Depreciation and amortisation expense
32 071 BGN
29 984 BGN
Tax expense (income)
5 003 BGN
3 313 BGN
Profit (loss) before tax
34 211 BGN
12 393 BGN
Profit (loss)
- BGN
- BGN
29 208 BGN
29 208 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
9 080 BGN
- BGN
9 080 BGN
- BGN
Assets
643 151 BGN
572 554 BGN
Liabilities
520 045 BGN
478 009 BGN
Cash flows from (used in) operating activities
47 956 BGN
18 580 BGN
Cash flows from (used in) investing activities
25 797 BGN
12 149 BGN
Cash flows from (used in) financing activities
15 879 BGN
11 287 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.